Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | Any |
Updated: | 7/28/2018 |
Start Date: | June 8, 2018 |
End Date: | June 2019 |
Contact: | Audrey Renson |
Email: | Audrey.Renson@nyumc.org |
Phone: | 212 263 0371 |
This is a prospective pilot study using a randomized, controlled, single blinded, crossover
trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers
versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable
wipes which are effective against MRSA. Each participant will then be randomly assigned to 7
days in either the intervention or the control arm. At the end of the 7 days participants
stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that
they are not in during the first 7 days.
The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days,
focusing on the difference between the intervention and the control periods. The secondary
endpoint is the rate of hospital acquired MRSA infection in patients treated by residents
during each period.
trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers
versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable
wipes which are effective against MRSA. Each participant will then be randomly assigned to 7
days in either the intervention or the control arm. At the end of the 7 days participants
stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that
they are not in during the first 7 days.
The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days,
focusing on the difference between the intervention and the control periods. The secondary
endpoint is the rate of hospital acquired MRSA infection in patients treated by residents
during each period.
Inclusion Criteria:
- Internal Medicine Residents
Exclusion Criteria:
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Marwa Moussa, MD
Phone: 212-263-0371
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials